NASDAQ:STOK

Stoke Therapeutics Stock Forecast

etoro logo Buy STOK
*Your capital is at risk
$29.30
-0.350 (-1.18%)
At Close: Jul 24, 2026
AI Analysis AI Analysis of STOK AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add STOK to Watchlist?
Some Reasons Why To Add STOK:
  • +123.7% price growth over the last year
  • High gross margin of 90.4%
  • Low bankruptcy risk (Altman Z-Score: 20.34)
PDF

Stoke Therapeutics, Inc. stock price ended at $29.30 on Friday, after losing 1.18%
(Updated on Jul 24, 2026)

Sell candidate since Jul 13, 2026 Loss -0.54%

The Stoke Therapeutics, Inc. stock price fell by -1.18% on the last day (Friday, 24th Jul 2026) from $29.65 to $29.30. During the last trading day the stock fluctuated 3.19% from a day low at $28.96 to a day high of $29.88. The price has fallen in 6 of the last 10 days and is down by -6.63% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -257 thousand shares and in total, 412 thousand shares were bought and sold for approximately $12.08 million.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.06% during the next 3 months and, with a 90% probability hold a price between $25.34 and $30.20 at the end of this 3-month period.

STOK Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, July 20, 2026, and so far it has risen 5.85%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Stoke Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $30.44. On a fall, the stock will find some support from the short-term average at $28.94. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Stoke Therapeutics, Inc. stock

Stoke Therapeutics, Inc. finds support from accumulated volume at $29.03 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.93 between high and low, or 3.19%. For the last week, the stock has had daily average volatility of 5.24%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (STOK) For The Upcoming Trading Day Of Monday 27th

For the upcoming trading day on Monday, 27th we expect Stoke Therapeutics, Inc. to open at $29.38, and during the day (based on 14 day Average True Range), to move between $28.55 and $30.05, which gives a possible trading interval of +/-$1.50 (+/-5.26%) up or down from last closing price. If Stoke Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 5.26% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $29.03 (0.92%) than the resistance at $31.00 (5.80%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Stoke Therapeutics, Inc. stock A Buy?

Stoke Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.694 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 27, 2026 - $29.38 ( 0.267%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

STOK Performance

Trading levels for STOK

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 30.30 3.42%
R2 29.95 2.22%
R1 29.73 1.47%
Price 29.30
S1 29.02 -0.94%
S2 28.81 -1.68%
S3 28.45 -2.89%

Accumulated Volume Support & Resistance Levels

Level Price
R3 32.72 11.67%
R2 32.00 9.22%
R1 31.00 5.80%
Price 29.30
S1 29.03 -0.92%
S2 28.81 -1.67%
S3 28.68 -2.12%

FAQ

What is the symbol for Stoke Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Stoke Therapeutics, Inc. is STOK and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Stoke Therapeutics, Inc. Stock?
Stoke Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Stoke Therapeutics, Inc. Stock?
Stoke Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Stoke Therapeutics, Inc. Stock.

What's the current price of Stoke Therapeutics, Inc. Stock?
As of the end of day on the Jul 24, 2026, the price of an Stoke Therapeutics, Inc. (STOK) share was $29.30.

What is the 52-week high and low for Stoke Therapeutics, Inc. Stock?
The 52-week high for Stoke Therapeutics, Inc. Stock is $40.22 and the 52-week low is $12.26.

What is the market capitalization of Stoke Therapeutics, Inc. Stock?
As of the Jul 24, 2026, the market capitalization of Stoke Therapeutics, Inc. is 1.825B.

When is the next earnings date for Stoke Therapeutics, Inc.?
The upcoming earnings date for Stoke Therapeutics, Inc. is Aug 11, 2026.
Click to get the best stock tips daily for free!
ABOUT STOKE THERAPEUTICS, INC.
Stoke Therapeutics
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. Its lead clinical candidate is STK-001, which is in phase I/IIa clinical trial to treat Dravet syndrome,...
GOLDEN STAR
Ticker Change Signal Date
KMT
$34.39
2.44% Jul 21
DHT
$17.31
6.59% Jul 13
NMRK
$15.02
2.46% Jun 24
JLL
$299.78
8.56% Jun 24
ROP
$331.60
10.78% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE